During this session we will:

• Identify drivers and barriers to successful relationships between managed care and manufacturers of oncology agents
• Explore evolving approaches to managing high-cost oncologics as costs of agents rise and combination therapies become more the norm
• Pinpoint the perceptions, attitudes and behaviors that drive successful plan-manufacturer relationships
• Learn why payers believe that their favorite companies, brands, and account teams provide superior value